{"id":"W4245473243","doi":"10.1093/annonc/mdy483.002","title":"Maintenance olaparib following platinum-based chemotherapy in newly diagnosed patients (pts) with advanced ovarian cancer (OC) and a BRCA1/2 mutation (BRCAm): Phase III SOLO1 trial","year":2018,"lang":"en","type":"article","venue":"Annals of Oncology","topic":"PARP inhibition in cancer therapy","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"Medicine; Olaparib; Oncology; Internal medicine; Clinical endpoint; Ovarian cancer; Placebo; BRCA mutation; Hazard ratio; Progression-free survival; Chemotherapy; Randomized controlled trial; Cancer; Confidence interval; Pathology","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005477431,0.0007689059,0.001439949,0.0002260851,0.0002286102,0.0008700818,0.0005901325,0.0006092596,0.002908484],"category_scores_gemma":[0.0007986538,0.0003236012,0.000853099,0.0002922709,0.0005248442,0.0007673787,0.0003383165,0.00234087,0.0005511141],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.000544385,"about_ca_system_score_gemma":0.0007698375,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0004351551,"about_ca_topic_score_gemma":0.001818542,"domain_scores_codex":[0.9998754,0.00004736138,0.000007443261,0.00002997286,0.00001105617,0.00002870368],"domain_scores_gemma":[0.9995483,0.00009867438,0.0000882258,0.00003330418,0.00001553137,0.0002161143],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.7336089,0.01110437,0.009703313,0.001417078,0.001675856,0.0003176085,0.000288209,0.003138628,0.01342003,0.0004450241,0.005760946,0.2191201],"study_design_scores_gemma":[0.7674438,0.1953268,0.02302343,0.000169668,0.001079031,0.000829433,0.0001543552,0.002868956,0.002699652,0.0009192543,0.005429601,0.00005606498],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9925385,0.003868781,0.0002390874,0.0005196962,0.0001188262,0.0003854349,0.0006701081,0.0000816625,0.001577865],"genre_scores_gemma":[0.9903903,0.003503366,0.0006808705,0.0007647382,0.0001561064,0.0004740047,0.001621397,0.00002044396,0.0023888],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.002908484,"threshold_uncertainty_score":0.009729922,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.04305060990265014,"score_gpt":0.3968295337381739,"score_spread":0.3537789238355238,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}